|
Q2 FY2026
As of Jun 27, 2026
|
Q1 FY2026
As of Mar 28, 2026
|
Q4 FY2025
As of Dec 27, 2025
|
Q3 FY2025
As of Sep 27, 2025
|
Q2 FY2025
As of Jun 28, 2025
|
Q1 FY2025
As of Mar 29, 2025
|
Q4 FY2024
As of Dec 28, 2024
|
Q3 FY2024
As of Sep 28, 2024
|
Q2 FY2024
As of Jun 29, 2024
|
Q1 FY2024
As of Mar 30, 2024
|
Q4 FY2023
As of Dec 30, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jul 1, 2023
|
Q1 FY2023
As of Apr 1, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 24, 2022
|
Q2 FY2022
As of Jun 25, 2022
|
Q1 FY2022
As of Mar 26, 2022
|
Q4 FY2021
As of Dec 25, 2021
|
Q3 FY2021
As of Sep 25, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Marketable securities | ||||||||||||||||||||
| SERP investment | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Federal income taxes recoverable | ||||||||||||||||||||
| State income taxes recoverable | ||||||||||||||||||||
| Income taxes recoverable | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating lease right-to-use | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible and other assets, net | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Current: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Operating leases | ||||||||||||||||||||
| Accrued self-insurance | ||||||||||||||||||||
| Deferred revenue, net | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| State income taxes payable | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Postretirement benefit obligations | ||||||||||||||||||||
| Accrued self-insurance | ||||||||||||||||||||
| Operating leases | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders' Equity | ||||||||||||||||||||
| Common stock, no par value, 100,800,000 shares authorized, 33,047,807 shares issued, 24,744,597 shares outstanding | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) (Net of deferred taxes of $475 in 2026 and $626 in 2025) | ||||||||||||||||||||
| Shareholders' equity before treasury stock | ||||||||||||||||||||
| Treasury stock at cost, 8,303,210 shares | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities and shareholders' equity |
Loading...